Stendra
Product Images NDC 72384-751

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Stendra (NDC 72384-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Metuchen Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Following Structural Formula For Avanafil Occurs As White Crystalline Powder, Molecular Formula C23h26cln7o3 And Molecular Weight Of 483.95 And Is Slightly Soluble In Ethanol, Practically Insoluble In Water, Soluble In 0.1 Mol/l Hydrochloric Acid. Stendra, For Oral Administration, Is Supplied As Oval, Pale Yellow Tablets Containing 50 mg, 100 mg, Or 200 mg Avanafil Debossed With Dosage Strengths. In Addition To The Active Ingredient, Avanafil, Each Tablet Contains The Following Inactive Ingredients: Mannitol, Fumaric Acid, Hydroxypropylcellulose, Low Substituted Hydroxypropylcellulose, Calcium Carbonate, Magnesium Stearate, And Ferric Oxide Yellow. (Stendra 01)

The Following Structural Formula For Avanafil Occurs As White Crystalline Powder, Molecular Formula C23h26cln7o3 And Molecular Weight Of 483.95 And Is Slightly Soluble In Ethanol, Practically Insoluble In Water, Soluble In 0.1 Mol/l Hydrochloric Acid. Stendra, For Oral Administration, Is Supplied As Oval, Pale Yellow Tablets Containing 50 mg, 100 mg, Or 200 mg Avanafil Debossed With Dosage Strengths. In Addition To The Active Ingredient, Avanafil, Each Tablet Contains The Following Inactive Ingredients: Mannitol, Fumaric Acid, Hydroxypropylcellulose, Low Substituted Hydroxypropylcellulose, Calcium Carbonate, Magnesium Stearate, And Ferric Oxide Yellow. (Stendra 01)
FDA Label Image

Figure 1: Median Change From Baseline In Sitting Systolic Blood Pressure, Healthy Volunteers Day 4 (Stendra 02)

Figure 1: Median Change From Baseline In Sitting Systolic Blood Pressure, Healthy Volunteers Day 4 (Stendra 02)
FDA Label Image

Figure 2: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Doxazosin (Stendra 03)

Figure 2: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Doxazosin (Stendra 03)
FDA Label Image

Figure 3: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Tamsulosin (Stendra 04)

Figure 3: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Tamsulosin (Stendra 04)
FDA Label Image

Figure 4: Plasma Avanafil Concentrations (mean ± Sd) Following A Single 50 mg Or 200 mg Stendra Dose (Stendra 05)

Figure 4: Plasma Avanafil Concentrations (mean ± Sd) Following A Single 50 mg Or 200 mg Stendra Dose (Stendra 05)
This appears to be random text with no specific meaning or context. It is not available.*
FDA Label Image

Principal Display Panelndc 76299-320-85stendra(avanafil) Tablets50 mgrx Only30 Tablets (Stendra 07)

Principal Display Panelndc 76299-320-85stendra(avanafil) Tablets50 mgrx Only30 Tablets (Stendra 07)
FDA Label Image

Principal Display Panelndc 76299-321-85stendra(avanafil) Tablets100 mgrx Only30 Tablets (Stendra 08)

Principal Display Panelndc 76299-321-85stendra(avanafil) Tablets100 mgrx Only30 Tablets (Stendra 08)
FDA Label Image

Principal Display Panelndc 76299-322-85stendra(avanafil) Tablets200 mgrx Only30 Tablets (Stendra 09)

Principal Display Panelndc 76299-322-85stendra(avanafil) Tablets200 mgrx Only30 Tablets (Stendra 09)
This text appears to be a mix of characters, symbols, numbers, and product names. It is difficult to understand and seems to be illegible due to errors. Therefore, the description cannot be provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.